Emergent Biosolutions is a biopharmaceutical company that provides vaccines and therapeutics against public health threats. It offers smallpox vaccines, anthrax immune globulin intravenous, botulism antitoxin heptavalent, fully human monoclonal antibodies, reactive skin decontamination lotion kits, obidoxime chloride auto-injectors, and other products. The company also develops an auto-ijector platform Emergard for intramuscular delivery of nerve agent antidotes and other emergency response medical treatments.